Search - tctmd.com

Displaying 641 - 660 of 1104

Sort: Relevancy | Date

News Daily News

NAC and/or Sodium Bicarbonate Fail to Add Protection Against Acute Kidney Damage in STEMI

Yael L. Maxwell

April 15, 2014

Presentation

High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Stenting

Presenter: Gilles Montalescot

April 11, 2014

News Daily News

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Caitlin E. Cox

April 11, 2014

News Conference News ACC 2014

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Caitlin E. Cox

April 02, 2014

News Conference News ACC 2014

Perioperative Aspirin Increases Major Bleeding After Noncardiac Surgery

L.A. McKeown

March 31, 2014

News Conference News ACC 2014

High-sensitivity Troponin Testing May Prevent Unnecessary Admissions for Chest Pain

L.A. McKeown

March 30, 2014

Presentation PCI Outcomes 2014

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Presenter: Christopher Granger

March 28, 2014

News Daily News

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

Caitlin E. Cox

March 27, 2014

News Industry News

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

March 27, 2014

News Industry News

New Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at American College of Cardiology Scientific Session (ACC.14)

March 24, 2014

News Daily News

PFO Closure Shows Promise in Alleviating Unprovoked Decompression Sickness in Divers

Jason Kahn

March 21, 2014

News Daily News

More Aggressive Treatment of Ruptured AAA in United States Reduces In-Hospital Mortality vs England

Caitlin E. Cox

March 20, 2014

News Daily News

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Caitlin E. Cox

March 20, 2014

News Daily News

ZES Continue to Match EES in All Comers at 4 Years

March 13, 2014

News Daily News

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

March 05, 2014

Presentation CTO 2014

Perforation: Type, Prevention, Mechanisms, and Management

Presenter: Georgios Sianos

February 28, 2014

News Daily News

与华法林或阿司匹林相比，阿哌沙班更具成本效益

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

Presentation

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Presenter: Paul Dorian

February 20, 2014

Advertisement

NAC and/or Sodium Bicarbonate Fail to Add Protection Against Acute Kidney Damage in STEMI

High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Stenting

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Perioperative Aspirin Increases Major Bleeding After Noncardiac Surgery

High-sensitivity Troponin Testing May Prevent Unnecessary Admissions for Chest Pain

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

New Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at American College of Cardiology Scientific Session (ACC.14)

PFO Closure Shows Promise in Alleviating Unprovoked Decompression Sickness in Divers

More Aggressive Treatment of Ruptured AAA in United States Reduces In-Hospital Mortality vs England

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

ZES Continue to Match EES in All Comers at 4 Years

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

Perforation: Type, Prevention, Mechanisms, and Management

与华法林或阿司匹林相比，阿哌沙班更具成本效益

Apixaban es Rentable comparado con Warfarina o Aspirina

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content